Press Releases

InVivo Therapeutics Reports Significant Improvement of Second and Third Patients Implanted with Neuro-Spinal Scaffold

Published: July 6, 2015

- Third Patient Improves from Complete to Incomplete Spinal Cord Injury – CAMBRIDGE, Mass. (July 6, 2015) – InVivo Therapeutics Holdings Corp. (NVIV) today announced a one- month post-implant update for the third study patient and a six-month post-implant update for the second study patient in the company’s ongoing pilot trial of its investigational Neuro-Spinal Scaffold in patients with complete acute spinal cord injury. In the time between implantation and the one-month post-injury assessment of the third study patient, the patient improved from a complete AIS A spinal cord injury to an incomplete AIS B spinal cord injury. The patient […]

View Article
InVivo Therapeutics to Present at Cantor Fitzgerald’s Inaugural Healthcare Conference

Published: July 1, 2015

CAMBRIDGE, Mass. (July 1, 2015) – InVivo Therapeutics Holdings Corp. (NVIV) today announced that Mark Perrin, Chief Executive Officer and Chairman, is scheduled to present at Cantor Fitzgerald’s Inaugural Healthcare Conference to be held Wednesday, July 8, 2015 at Le Parker Méridien Hotel in New York City, NY. The company’s presentation will be at 10:45 A.M. (EDT). Mr. Perrin said, “I am pleased to be presenting at Cantor’s Inaugural Healthcare Conference. This presentation opportunity is part of our larger communications effort to inform investors and other key constituencies of the significant progress the company has achieved to establish our leadership […]

View Article
InVivo Therapeutics Announces Rutgers New Jersey Medical School as New Clinical Site for Neuro-Spinal Scaffold

Published: June 30, 2015

CAMBRIDGE, Mass. (June 30, 2015) – InVivo Therapeutics Holdings Corp. (NVIV) today announced that Rutgers New Jersey Medical School in Newark, NJ has been added as a clinical site in the company’s ongoing pilot study of its investigational Neuro-Spinal Scaffold in patients with acute spinal cord injury (SCI). Robert Heary, M.D., Professor of Neurological Surgery and Director of the Spine Center, has been named Principal Investigator at this site. The Spine Center is part of the Northern New Jersey Spinal Cord Injury System, one of 14 federally designated Spinal Cord Injury Model Systems in the United States and the only […]

View Article
InVivo Therapeutics is Added to Russell Global, Russell 3000®, Russell 2000®, and Russell Microcap® Indexes

Published: June 29, 2015

- Enhanced Liquidity and Exposure to Benefit Shareholders – CAMBRIDGE, Mass. (June 29, 2015) – InVivo Therapeutics Holdings Corp. (NVIV) today announced that the company has been added to the Russell Global, Russell 3000®, Russell 2000®, and Russell Microcap ® Indexes on June 26, 2015. “I am pleased by InVivo’s inclusion in the various Russell Indexes,” said Mark Perrin, InVivo’s CEO and Chairman. “The news comes less than three short months after our NASDAQ listing, and I’m happy to be executing on the long-term benefits of being NASDAQ-listed. We expect to see a significant increase in demand and liquidity from […]

View Article
InVivo Therapeutics to Present at the 33rd Annual Symposium of the National Neurotrauma Society

Published: June 23, 2015

CAMBRIDGE, Mass. (June 23, 2015) – InVivo Therapeutics Holdings Corp. (NVIV) today announced that Richard Layer, Ph.D., Director of Research, will be giving a poster presentation at the National Neurotrauma Society (NNS) 2015 Symposium to be held June 28 – July 1, 2015 in Santa Fe, NM. The abstract, titled “Biodegradable Neuro-Spinal Scaffold Preserves Spinal Cord Architecture Following Spinal Contusion Injury in Rats”, was chosen by the NNS Abstract Committee for poster presentation on the basis of quality and scientific merit. “InVivo looks forward to continuing to increase our interactions with the scientific community. It’s a significant effort being led […]

View Article
InVivo Therapeutics Receives Notice of Allowance on Patent Covering Broader Compositions for Neuro-Spinal Scaffold and Neuro-Spinal Scaffold Plus Stem Cells

Published: June 22, 2015

CAMBRIDGE, Mass. (June 22, 2015) – InVivo Therapeutics Holdings Corp. (NVIV) today announced that it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for U.S. Patent Application No. 14/496,742, titled “Methods and Compositions for the Treatment of Open and Closed Wound Spinal Cord Injuries”. The application covers InVivo’s investigational Neuro-Spinal Scaffold, which is currently being studied in a pilot clinical trial and has been successfully implanted in three patients. Also covered is InVivo’s Neuro-Spinal Scaffold Plus Stem Cells program, which is in early stages of development for the treatment of chronic spinal cord […]

View Article
InVivo Therapeutics Announces Posting of Management Presentation Recording from Annual Shareholders Meeting

Published: June 19, 2015

CAMBRIDGE, Mass. (June 19, 2015) – InVivo Therapeutics Holdings Corp. (NVIV) today announced the posting of the management presentation recording from the 2015 Annual Shareholders Meeting held on June 16th, 2015. The recording is available on the investor relations page of InVivo’s website – http://www.invivotherapeutics.com/investor-relations/annual-meeting/. “It was rewarding to report on the progress InVivo has made in the last year. I’m pleased with the support and feedback we received from our shareholders and look forward to continued, transparent communications,” said Mark Perrin, InVivo’s Chief Executive Officer and Chairman. About the Neuro-Spinal Scaffold Following an acute spinal cord injury, the biodegradable Neuro-Spinal […]

View Article
InVivo Therapeutics Co-Founder Dr. Robert Langer to Highlight InVivo Scientific Progress in Closing Keynote Address at the International Society for Stem Cell Research 2015 Annual Meeting

Published: June 18, 2015

CAMBRIDGE, Mass. (June 18, 2015) – InVivo Therapeutics Holdings Corp. (NVIV) today announced that Co-Founder Robert Langer, Sc.D., will be making the Closing Keynote Address at the Annual Meeting of the International Society for Stem Cell Research (ISSCR), to be held June 24-27, 2015 in Stockholm, Sweden. His keynote address will be held during the last plenary session titled Making Tissues and Organs. “It’s a great honor to be chosen for this speaking engagement. In my talk, I’ll be discussing many exciting advancements that have been made in the field of tissue engineering, and will be highlighting the investigational Neuro-Spinal […]

View Article
InVivo Therapeutics Announces Appointment of Ann Merrifield as Lead Director

Published: June 16, 2015

CAMBRIDGE, Mass. (June 16, 2015) – InVivo Therapeutics Holdings Corp. (NVIV) today announced the Company’s Board of Directors has appointed independent director Ann Merrifield to the newly created position of Lead Director. The Lead Director will serve as a liaison between the Chairman and non- management directors, chair all executive sessions, and work with the Chairman on meeting agendas and time schedules for the Board of Directors. “Ann Merrifield’s deep industry knowledge and expertise has proven to be invaluable since joining the Board of Directors in November 2014,” said Mark Perrin, InVivo’s Chief Executive Officer and Chairman. “Her proven leadership […]

View Article
InVivo Therapeutics Announces James Guest, M.D., Ph.D., Has Joined Scientific Advisory Board

Published: June 15, 2015

CAMBRIDGE, Mass. (June 15, 2015) – InVivo Therapeutics Holdings Corp. (NVIV) today announced that James Guest, M.D., Ph.D., has joined its Scientific Advisory Board. Dr. Guest is currently a Professor of Neurological Surgery at the Miller School of Medicine and the Miami Project to Cure Paralysis in Miami, FL. Dr. Guest’s extensive contributions to the field of spinal cord injury, both in terms of medical practice and research, span over two decades. He’s held numerous hospital appointments such as attending neurosurgeon at the Barrow Neurological Institute, West Palm Beach VA Medical Center, the University of Miami Hospital, and Chief of […]

View Article

The information in the press releases on these pages was factually accurate on the date of publication. These press releases remain on the InVivo website for historical purposes only. InVivo assumes no duty to update the information to reflect subsequent developments. Readers should not rely upon the information in these pages as current or accurate after their publication dates.